IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, offering promising improvements throughout several healthcare and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, more trustworthy substitute for therapeutic use, notab